{
  "id": "a15e8869c078",
  "type": "finding",
  "topic": "Zepbound Q4 2025 revenue estimation",
  "summary": "Zepbound Q3 2025 global revenue was $3,588.1M. Historical quarterly trajectory shows strong growth but decelerating sequential gains. Q4 2025 estimate centered at $4,000-4,300M based on multiple approaches.",
  "content": "Historical Zepbound global revenue (millions USD):\nQ1 2024: $517.4, Q2 2024: $1,243.3, Q3 2024: $1,257.8, Q4 2024: $1,907.2\nQ1 2025: $2,311.9, Q2 2025: $3,381.4, Q3 2025: $3,588.1\n\nKey data points:\n- Q3 2025 US Zepbound: $3,570M, International: ~$18M\n- Lilly 2025 guidance raised to $63.0-63.5B after Q3\n- YoY growth rates: Q1 347%, Q2 172%, Q3 185%\n- Sequential growth: Q2→Q3 only +6.1%, Q3→Q4 2024 was +51.6%\n- Barchart (Jan 13, 2026): Analysts expect Q4 2025 EPS of $7.47\n- Full year 2024 Zepbound: $4,925.7M, Q1-Q3 2025: $9,281.4M\n\nMultiple estimation approaches converge on $3,800-4,500M range for Q4 2025",
  "sources": [
    "https://www.statista.com/statistics/1636037/eli-lilly-zepbound-revenue/",
    "https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2025-financial-results-highlights-rd",
    "https://www.barchart.com/story/news/37015541/what-to-expect-from-eli-lillys-q4-2025-earnings-report"
  ],
  "confidence": 0.7,
  "question_id": 0,
  "report_path": "",
  "created_at": "2026-02-06T22:17:04.215405Z"
}